XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Preferred Stock Series A
Preferred Stock Series A-1
Preferred Stock Series B
Preferred Stock Series B-1
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]         $ 9,569,000 $ 14,083,000 $ 18,854,000 $ 4,682,000
Beginning balance (in shares) at Dec. 31, 2020 [1]         26,157,622 20,238,201 12,366,306 3,047,183
Increase (Decrease) in Temporary Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) [1]         (26,157,622) (20,238,201) (12,366,306) (3,047,183)
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization [1]         $ (9,569,000) $ (14,083,000) $ (18,854,000) $ (4,682,000)
Ending balance (in shares) at Dec. 31, 2021 [1]         0 0 0 0
Ending balance at Dec. 31, 2021 [1]         $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2020 [1]   22,118,619            
Beginning balance at Dec. 31, 2020 $ (68,009,000) $ 2,000 [1] $ 3,707,000 $ (71,718,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) [1]   61,809,312            
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 47,188,000 $ 6,000 [1] 47,182,000          
Conversion of convertible promissory notes to common stock in connection with the reverse recapitalization (in Shares) [1]   4,633,507            
Conversion of convertible promissory notes to common stock in connection with the reverse recapitalization (Note 3) 7,122,000 $ 1,000 [1] 7,121,000          
Beneficial conversion feature of convertible promissory notes in connection with the reverse recapitalization 26,061,000   26,061,000          
Conversion of preferred stock warrants and common stock warrants in connection with the reverse recapitalization (in shares) [1]   1,771,231            
Conversion of preferred stock warrants and common stock warrants in connection with the reverse recapitalization 8,571,000   8,571,000          
Reverse recapitalization transaction, net of fees (in Shares) [1]   21,959,227            
Reverse recapitalization transaction, net of fees $ 101,261,000 $ 2,000 [1] 101,259,000          
Issuance of common stock upon exercise of stock options (in shares) 704,672 704,672 [1]            
Issuance of common stock upon exercise of stock options $ 442,000   442,000          
Stock-based compensation 4,259,000   4,259,000          
Net loss (71,704,000)     (71,704,000)        
Ending balance (in shares) at Dec. 31, 2021 [1]   112,996,568            
Ending balance at Dec. 31, 2021 $ 55,191,000 $ 11,000 [1] 198,602,000 (143,422,000)        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]         $ 0 $ 0 $ 0 $ 0
Ending balance (in shares) at Dec. 31, 2022         0 0 0 0
Ending balance at Dec. 31, 2022         $ 0 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 816,866 816,866            
Issuance of common stock upon exercise of stock options $ 258,000   258,000          
Issuance of common stock for restricted stock units vesting (in shares)   1,324,812            
Issuance of common stock for restricted stock units vesting 1,000 $ 1,000            
Issuance of common stock for employee stock purchase plan (in shares)   249,889            
Issuance of common stock for employee stock purchase plan 359,000   359,000          
Stock-based compensation 12,892,000   12,892,000          
Net loss (79,336,000)     (79,336,000)        
Ending balance (in shares) at Dec. 31, 2022   115,388,135            
Ending balance at Dec. 31, 2022 $ (10,635,000) $ 12,000 $ 212,111,000 $ (222,758,000)        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance         $ 0 $ 0 $ 0 $ 0
[1] The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger, have been retrospectively adjusted as shares reflecting the exchange ratio of approximately 2.053 established in the Merger (see Note 3)